Crossmark

DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1038/s41598-024-61615-0

Published Online: 2024-05-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Bolun

Xue, Junshuai

Xu, Bowen

Chang, Jianping

Li, Xin

Huang, Zhen

Zhao, Hong

Cai, Jianqiang
Funding

Funding for this research was provided by:

CAMS Initiative for Innovative Medicine (2021-I2M-1-015)

National Natural Science Foundation of China (81972311)

National Natural Science Foundation of China (82141127)

the Sanming Project of Medicine in Shenzhen (No. SZSM202011010)

the CAMS Innovation Fund for Medical Sciences (No. 2021-I2M-1-066)
License Information

Text and Data Mining valid from 2024-05-10

Version of Record valid from 2024-05-10
More Information

Article History

Received: 16 January 2024

Accepted: 7 May 2024

First Online: 10 May 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below